The Global NGS Sample Preparation Market is expected to reach US$ 6,059 million by 2031. The market is anticipated to register a CAGR of 12.3% during 2025–2031. Increasing adoption of next-generation sequencing (NGS) technologies, growing demand for precision medicine, rising genomic research activities, and advancements in molecular diagnostics are driving market expansion. NGS sample...
The Esoteric Testing Market is experiencing significant growth due to the increasing demand for specialized diagnostic testing, rising prevalence of complex diseases, and advancements in molecular diagnostics and laboratory technologies. The global esoteric testing market size is projected to reach US$ 61.11 billion by 2034, up from US$ 25.55 billion in 2025. The market is anticipated to...
The Anatomic Pathology Market is experiencing significant growth as healthcare providers increasingly depend on advanced diagnostic technologies for accurate disease detection and personalized treatment planning. Anatomic pathology remains a critical component of modern healthcare, particularly in oncology, where tissue-based diagnosis plays a vital role in determining appropriate therapeutic...
The Metastatic Melanoma Drugs Market is experiencing remarkable growth as pharmaceutical innovations continue to transform the treatment landscape for advanced skin cancer. Increasing adoption of immune checkpoint inhibitors, targeted therapies, and combination treatment approaches has significantly improved survival outcomes for patients diagnosed with metastatic melanoma. The market was...
The Metastatic Melanoma Drugs Market focuses on pharmaceutical treatments used to manage melanoma that has spread beyond its original site to other parts of the body. These treatments include immunotherapy, targeted therapy, and other systemic approaches designed to control disease progression and improve patient outcomes. According to The Insight Partners estimates, the market was valued at...
Global 3D Cell Culture Market Climbs from USD 1.80 Billion in 2025 toward USD 5.09 Billion by 2032, Expanding at an Accelerated 16.00% CAGR as Organoids, Microfluidic Organ-on-a-Chip Systems, and Non-Animal Testing Mandates Transform Preclinical Drug Discovery
Strategic Executive Intelligence on Scaffold-Based Hydrogels, Scaffold-Free Hanging Drop and Magnetic Levitation Platforms,...
Rare diseases pose a particular challenge for drug developers: small patient populations, thin evidence bases, and diagnostic paths that historically led clinicians astray. Blastic plasmacytoid dendritic cell neoplasm, or BPDCN, is a case in point — a rare and aggressive hematologic malignancy, derived from precursor plasmacytoid dendritic cells, that primarily affects the skin, bone...
Polaris Market Research presents its latest market research report, titled Hereditary Testing Market Size and Share Global Analysis Report. It is a comprehensive market research report analyzing the fast-evolving hereditary testing market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The...
The North America EGFR-TKI for Advanced NSCLC Market is expected to maintain strong growth through 2034, supported by advances in precision oncology, increasing adoption of biomarker-driven treatment approaches, and continued innovation in targeted therapies for EGFR-mutated non-small cell lung cancer. The region benefits from a well-established oncology research ecosystem, advanced molecular...
Polaris Market Research releases its new research report on the digital PCR market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a comprehensive...
According to the latest report published by Data Bridge Market Research, the Molecular Point of Care Testing (using NAAT) Market
CAGR Value
The global molecular point of care testing (using NAAT) market size was valued at USD 37.93 billion in 2024 and is expected to reach USD 86.17 billion by 2032, at a CAGR of 1.08% during the forecast period...
Precision Medicine Software Market: Key Segmentation, Growth Drivers, Trends and Recent Developments
The global Precision Medicine Software Market is experiencing significant growth as healthcare systems, pharmaceutical companies, research institutions, and biotechnology organizations increasingly use advanced software to support personalized diagnosis, treatment selection,...
